<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="retraction" xmlns:xlink="http://www.w3.org/1999/xlink">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">OR</journal-id>
<journal-title-group>
<journal-title>Oncology Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1021-335X</issn>
<issn pub-type="epub">1791-2431</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/or.2020.7828</article-id>
<article-id pub-id-type="publisher-id">or-45-01-0407</article-id>
<article-categories>
<subj-group>
<subject>Retraction</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Long non-coding RNA MEG3 inhibits cell growth of gliomas by targeting miR-93 and inactivating PI3K/AKT pathway</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Ling</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Liang</surname><given-names>Xin</given-names></name></contrib>
<contrib contrib-type="author"><name><surname>Li</surname><given-names>Yuxiong</given-names></name></contrib>
</contrib-group>
<pub-date pub-type="ppub"><month>01</month><year>2021</year></pub-date>
<pub-date pub-type="epub"><day>27</day><month>10</month><year>2020</year></pub-date>
<volume>45</volume>
<issue>1</issue>
<fpage>407</fpage>
<lpage>407</lpage>
<permissions>
<copyright-statement>Copyright: &#x00A9; Zhang et al.</copyright-statement>
<copyright-year>2020</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p></license>
</permissions>
</article-meta>
</front>
<body>
<p>Oncol Rep 38: <related-article xmlns:xlink="http://www.w3.org/1999/xlink" related-article-type="retracted-article" vol="38" page="2408" id="RA1" xlink:href="10.3892/or.2017.5871" ext-link-type="doi">2408-2416</related-article>, 2017; DOI: 10.3892/or.2017.5871</p>
<p>Following the publication of this paper, it was drawn to the authors attention by an interested reader that certain of the tumours featured in Fig. 6A of the above paper were strikingly similar to those featured in Fig. 8A of an article appearing in <italic>International Journal of Oncology</italic> (Fan F-Y, Deng R, Yi H, Sun H-P, Zeng Y, He G-C and Su Y: The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma. Int J Oncol 51: 316&#x2013;326, 2017).</p>
<p>The Editor asked the authors for an explanation to account for the appearance of strikingly similar data in their paper independently, and they responded to request that the paper be retracted from <italic>Oncology Reports</italic>. All the authors agreed that the article should be retracted. The Editor apologizes to the readership for any inconvenience caused.</p>
</body>
</article>